| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.49B | $2.12B | $1.97B |
| YoY Revenue Growth % | +17.7% | +7.3% | — |
| Gross Profit | $572.3M | $426.1M | — |
| Gross Margin % | 23.0% | 20.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $405.9M | $264.6M | $205.8M |
| Operating Margin % | 16.3% | 12.5% | 10.4% |
| Net Income (GAAP) | $290.2M | $257.5M | $138.7M |
| EBITDA (Normalized) | $467.8M | $329.4M | $276.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $440.0M | $497.1M | $478.6M |
| Capital Expenditures (CapEx) | $77.3M | $81.0M | $88.8M |
| Free Cash Flow (FCF) | $362.7M | $416.1M | $389.8M |
| FCF Margin % | 14.6% | 19.7% | 19.8% |
| Return on Invested Capital (ROIC %) | 32.3% | 48.2% | 4.3% |
| Cash & Short-Term Equivalents | $390.7M | $664.2M | — |
| Total Debt (Short + Long Term) | $275.9M | $289.9M | $1.47B |
| Total Stockholders' Equity | $1.11B | $808.1M | $3.02B |